CVI Holdings’s ZyVersa Therapeutics ZVSA Stock Holding History

CVI Holdings’s Portfolio ZVSA Stock Details ZVSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-714	Closed	-$2.5M	–	647
2022 Q3	$2.5M	Hold	714	–	–	0.19%	185
2022 Q2	$2.48M	Hold	714	–	–	0.18%	202
2022 Q1	$2.47M	Buy	+714	New	+$2.47M	0.16%	222

Other funds holding ZVSA

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

CVI Holdings's ZVSA Position: Q4 2022 in Review

CVI Holdings sold out of ZyVersa Therapeutics (ZVSA) in Q4 2022, closing a stake of 714 shares — an estimated $2.5M sold.

CVI Holdings first reported a position in ZVSA in Q1 2022 and held it in 3 quarters. The position peaked at $2.5M in Q3 2022. 2 funds tracked by Wall St. Rank hold ZVSA as of Q4 2022.

CVI Holdings reported no remaining ZyVersa Therapeutics position as of Q4 2022 after selling out during the quarter.
CVI Holdings sold 714 ZyVersa Therapeutics shares in Q4 2022, an estimated $2.5M.
CVI Holdings first reported a position in ZyVersa Therapeutics in Q1 2022 and held it in 3 quarters.
CVI Holdings's ZyVersa Therapeutics position peaked at $2.5M in Q3 2022.
2 funds tracked by Wall St. Rank held ZyVersa Therapeutics as of Q4 2022.

Based on CVI Holdings's 13F filing for Q4 2022, filed 14 Feb 2023.